KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to -$427.8 million.

  • Edwards Lifesciences' Cash from Investing Activities fell 11583.45% to -$427.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 13758.31%. This contributed to the annual value of $2.3 billion for FY2024, which is 123078.25% up from last year.
  • As of Q3 2025, Edwards Lifesciences' Cash from Investing Activities stood at -$427.8 million, which was down 11583.45% from -$172.1 million recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' Cash from Investing Activities registered a high of $2.7 billion during Q3 2024, and its lowest value of -$965.9 million during Q4 2021.
  • Its 5-year average for Cash from Investing Activities is $26.4 million, with a median of $14.1 million in 2023.
  • Over the last 5 years, Edwards Lifesciences' Cash from Investing Activities had its largest YoY gain of 1252000.0% in 2024, and its largest YoY loss of 419007.09% in 2024.
  • Quarter analysis of 5 years shows Edwards Lifesciences' Cash from Investing Activities stood at -$965.9 million in 2021, then surged by 109.8% to $94.7 million in 2022, then tumbled by 85.11% to $14.1 million in 2023, then tumbled by 4190.07% to -$576.7 million in 2024, then increased by 25.82% to -$427.8 million in 2025.
  • Its Cash from Investing Activities was -$427.8 million in Q3 2025, compared to -$172.1 million in Q2 2025 and $85.3 million in Q1 2025.